If what Joe says about safety, efficacy and long term immunity is true the window won't close. The initial market excitement will be diminished to a degree. I wasn't expecting $250/share like NVAX anyway. That would be like winning the Powerball lottery. I would probably wind up broke and living in my Dad's basement within a year.
Generex Biotechnology Corp. (GNBT) Stock Research Links